| __timestamp | ADMA Biologics, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 15635076 |
| Thursday, January 1, 2015 | 7015946 | 23943601 |
| Friday, January 1, 2016 | 7688238 | 23689111 |
| Sunday, January 1, 2017 | 6229587 | 41006114 |
| Monday, January 1, 2018 | 3926120 | 51379106 |
| Tuesday, January 1, 2019 | 2343848 | 32705593 |
| Wednesday, January 1, 2020 | 5907013 | 53274000 |
| Friday, January 1, 2021 | 3646060 | 85352000 |
| Saturday, January 1, 2022 | 3613764 | 51999000 |
| Sunday, January 1, 2023 | 3300000 | 59471000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Summit Therapeutics Inc. and ADMA Biologics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Summit Therapeutics consistently allocated a significant portion of its resources to R&D, peaking in 2021 with a staggering 85% increase compared to 2014. In contrast, ADMA Biologics showed a more conservative approach, with a notable 65% decrease in R&D spending over the same period. This divergence highlights Summit's aggressive pursuit of new therapies, while ADMA's strategy may reflect a focus on optimizing existing products. As the biotech landscape evolves, these spending patterns offer valuable insights into each company's strategic priorities and potential future breakthroughs.
Comparing Innovation Spending: Eli Lilly and Company and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Summit Therapeutics Inc.
R&D Insights: How Summit Therapeutics Inc. and Halozyme Therapeutics, Inc. Allocate Funds
Research and Development Investment: Summit Therapeutics Inc. vs Alkermes plc
Summit Therapeutics Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Summit Therapeutics Inc. and MannKind Corporation
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and MiMedx Group, Inc.
Axsome Therapeutics, Inc. or ADMA Biologics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How ADMA Biologics, Inc. and MiMedx Group, Inc. Allocate Funds